Statistics

Total Visits

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants85

Select a period of time:

Number of views in the range

Views
A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants42

Views

Views
March 202514
April 20253
May 20251
June 20254
July 202516
August 20252
September 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States19
Singapore12
Brazil5
United Kingdom2
Ecuador1
Spain1
Mexico1
South Africa1
 

Top cities views

Views
Brasília1
Camaçari1
Chicago1
Columbus1
Conyers1
Council Bluffs1
Dallas1
Erie1
Johannesburg1
Lancaster1